Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0I1IK
|
|||
Former ID |
DNC007558
|
|||
Drug Name |
7-fluoroindirubin-3-acetoxime
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H12FN3O3
|
|||
Canonical SMILES |
CC(=O)ON=C1C2=CC=CC=C2N=C1C3=C(NC4=C3C=CC=C4F)O
|
|||
InChI |
1S/C18H12FN3O3/c1-9(23)25-22-16-10-5-2-3-8-13(10)20-17(16)14-11-6-4-7-12(19)15(11)21-18(14)24/h2-8,21,24H,1H3/b22-16-
|
|||
InChIKey |
NFIUKUJUBYCMTC-JWGURIENSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Aurora B messenger RNA (AURKB mRNA) | Target Info | Inhibitor | [1] |
Aurora kinase C (AURKC) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Oocyte meiosis | |||
Pathway Interaction Database | Aurora B signaling | |||
Signaling by Aurora kinases | ||||
Aurora C signaling | ||||
FOXM1 transcription factor network | ||||
Aurora A signaling | ||||
Reactome | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | |||
Separation of Sister Chromatids | ||||
Resolution of Sister Chromatid Cohesion | ||||
RHO GTPases Activate Formins | ||||
Mitotic Prometaphase | ||||
WikiPathways | Mitotic Metaphase and Anaphase | |||
Mitotic Prometaphase | ||||
Regulation of Microtubule Cytoskeleton | ||||
miR-targeted genes in lymphocytes - TarBase | ||||
miR-targeted genes in epithelium - TarBase | ||||
APC/C-mediated degradation of cell cycle proteins | ||||
EGF/EGFR Signaling Pathway | ||||
JAK/STAT | ||||
Gastric Cancer Network 1 | ||||
Integrated Breast Cancer Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted in... J Med Chem. 2007 Aug 23;50(17):4027-37. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.